Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab

Clinical Colorectal Cancer

Volumn 11, Issue 2, 2012, Pages 119-126

  Bruera, Gemma ^a   Cannita, Katia ^a   Giuliante, Felice ^b   Baldi, Paola Lanfiuti ^a   Vicentini, Roberto ^c   Marchetti, Paolo ^d   Nuzzo, Gennaro ^b   Antonucci, Adelmo ^c   Ficorella, Corrado ^a   Ricevuto, Enrico ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAN SALVATORE HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Integrated treatments; Intensive chemotherapy; Liver limited; Liver only; Liver surgery

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FLUOROURACIL TEVA; IRINOTECAN; OXALIPLATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG EFFICACY; FEMALE; HUMAN; INOPERABLE CANCER; LIVER METASTASIS; LIVER SURGERY; LUNG METASTASIS; MALE; METASTASIS RESECTION; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84860740352     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.11.002     Document Type: Article

References (48)

1. B. Nordlinger, E. Van Cutsem, P. Rougier Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group Eur J Cancer 43 2007 2037 2045 (Pubitemid 47380368)
2. E. Van Cutsem, B. Nordlinger, R. Adam European Colorectal Metastases Treatment Group Toward a pan-European consensus on the treatment of patients with colorectal liver metastases Eur J Cancer 42 2006 2212 2221 (Pubitemid 44307626)
3. G.J. Poston, J. Figueras, F. Giuliante Urgent need for a new staging system in advanced colorectal cancer J Clin Oncol 26 2008 4828 4833
4. J. Figueras, J. Torras, C. Valls Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients Dis Colon Rectum 50 2007 478 488 (Pubitemid 46701611)
5. D. Elias, L. Sideris, M. Pocard Results of R0 resection for colorectal liver metastases associated with extrahepatic disease Ann Surg Oncol 11 2004 274 280 (Pubitemid 40486767)
6. G. Folprecht, A. Grothey, S. Alberts Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann Oncol 16 2005 1311 1319 (Pubitemid 41158476)
7. S. Giacchetti, M. Itzhaki, G. Gruia Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery Ann Oncol 10 1999 663 669 (Pubitemid 29342371)
8. C. Pozzo, M. Basso, A. Cassano Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients Ann Oncol 15 2004 933 939 (Pubitemid 39004350)
9. S.R. Alberts, W.L. Horvath, W.C. Sternfeld Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study J Clin Oncol 23 2005 9243 9249
10. C. Barone, G. Nuzzo, A. Cassano Final analysis of colorectal cancer patients treated with Irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases Br J Cancer 97 2007 1035 1039 (Pubitemid 47587006)
11. A. Falcone, S. Ricci, I. Brunetti Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest J Clin Oncol 25 2007 1670 1676 (Pubitemid 46797946)
12. G. Masi, E. Vasile, F. Loupakis Triplet combination of fluoropyrimidimes, oxaliplatin, and irinotecan in the first-line treatment of metastatic colorectal cancer Clin Colorectal Cancer 7 2008 7 14 (Pubitemid 351252446)
13. M. Ychou, F. Viret, A. Kramar Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases Cancer Chemother Pharmacol 62 2008 195 201 (Pubitemid 351692073)
14. E. Van Cutsem, F. Rivera, S. Berry, D. Cunningham First BEAT investigators Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study Ann Oncol 20 2009 1842 1847
15. L.B. Saltz, S. Clarke, E. Diaz-Rubio Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study J Clin Oncol 26 2008 2013 2019
16. J. Cassidy, S. Clarke, E. Diaz-Rubio Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer J Clin Oncol 26 2008 2006 2012
17. B. Gruenberger, D. Tamandl, J. Schueller Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer J Clin Oncol 26 2008 1830 1835
18. E. Van Cutsem, C.H. Kohne, E. Hitre Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer N Engl J Med 360 2009 1408 1417
19. C. Bokemeyer, I. Bondarenko, A. Makhson Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer J Clin Oncol 27 2008 663 671
20. G. Folprecht, T. Gruenberger, W.O. Bechstein Tumour response and secondary respectability of colorectal liver metastases following neoadjuvant chemotherapy with Cetuximab: the CELIM randomized phase 2 trial Lancet Oncol 11 2010 38 47
21. B. Nordlinger, E. Van Cutsem, T. Gruenberger European Colorectal Metastases Treatment Group Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel Ann Oncol 20 2009 958 992
22. H. Bismuth, R. Adam, F. Lévi Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy Ann Surg 224 1996 509 522 (Pubitemid 26337559)
23. R. Adam, V. Delvart, G. Pascal Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 2004 644 658 (Pubitemid 39281287)
24. R. Adam, D.A. Wicherts, R.J. de Haas Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 27 2009 1829 1835
25. P.C. Simmonds, J.N. Primrose, J.L. Colquitt Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies Br J Cancer 94 2006 982 999
26. G. Bruera, A. Santomaggio, K. Cannita "Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study BMC Cancer 10 2010 567
27. C. Ficorella, E. Ricevuto, M.F. Morelli Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: a dose-finding study Oncol Rep 15 2006 1345 1350
28. M.F. Morelli, A. Santomaggio, E. Ricevuto Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study Oncol Rep 23 2010 1635 1640
29. G. Bruera, E. Ricevuto Intensive chemotherapy of metastatic colorectal cancer: weighing between safety and clinical efficacy Expert Opin Biol Ther 11 2011 1 4
30. D.E. Kleiner, E.M. Brunt, M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321 (Pubitemid 40770284)
31. P. Therasse, S.G. Arbuck, E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
32. E.L. Kaplan, P. Meier Nonparametric estimation of incomplete observations J Am Stat Assoc 53 1958 457 481
33. G. Steele, T.S. Ravikumar Resection of hepatic metastases from colorectal cancer Ann Surg 210 1989 127 138 (Pubitemid 19188702)
34. R. Adam, E. Avisar, A. Ariche Five-years survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal Ann Surg Oncol 8 2001 347 353 (Pubitemid 32422861)
35. G. Masi, F. Loupakis, L. Salvatore Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial Lancet Oncol 11 2010 845 852
36. C. Garufi, A. Torsello, S. Tumolo Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial Br J Cancer 103 2010 1542 1547
37. B. Gruenberger, W. Scheithauer, R. Punzengruber Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer 8 2008 120
38. B. Nordlinger, H. Sorbye, B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial Lancet 371 2008 1007 1016 (Pubitemid 351392040)
39. D.G. Blazer, Y. Kishi, D.M. Maru Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 25 2008 5344 5351
40. J.N. Vauthey, T.M. Pawlik, D. Ribero Chemotherapy regimens predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2006 2065 2072 (Pubitemid 46622116)
41. A.A. Parikh, B. Gentner, T.T. Wu Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy J Gastrointest Surg 7 2003 1082 1088 (Pubitemid 37526731)
42. T. Aloia, M. Sebagh, M. Plasse Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 2006 4983 4990 (Pubitemid 46631400)
43. D.A. Kooby, Y. Fong, A. Suriawinata Impact of steatosis on perioperative outcome following hepatic resection J Gastrointest Surg 7 2003 1034 1044 (Pubitemid 37524071)
44. R. Vetelainen, A. van Vliet, D.J. Gouma Steatosis as a risk factor in liver surgery Ann Surg 245 2007 20 30 (Pubitemid 46035431)
45. M. Karoui, C. Penna, M. Amin-Hashem Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 2006 1 7 (Pubitemid 43054046)
46. A. Okines, O. del Puerto, D. Cunningham Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomized phase-III NO16966 trial Br J Cancer 101 2009 1033 1038
47. S. Kopetz, G.J. Chang, M.J. Overman Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol 27 2009 3677 3683
48. J.N. Primrose Surgery for colorectal liver metastases Br J Cancer 102 2010 1313 1318